These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37883725)

  • 1. Radiotherapy for Brain Metastases Near the End of Life: Characterizing Patients and Tumor Features.
    Silva SB; Barreto RB; de Oliveira FCG; Martin GSD; Takiguchi OMY; Chirichela IA; Miranda MHF; Bodnar D; Alves Reis LA; Pereira GCB; Miranda IL; Pereira BR; Arruda GV; Peria FM
    JCO Glob Oncol; 2023 Sep; 9():e2300143. PubMed ID: 37883725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
    Partl R; Richtig E; Avian A; Berghold A; Kapp KS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.
    Heisterkamp C; Haatanen T; Schild SE; Rades D
    Strahlenther Onkol; 2010 Feb; 186(2):70-75. PubMed ID: 20127223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
    Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?
    Nieder C; Nestle U; Motaref B; Walter K; Niewald M; Schnabel K
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):297-302. PubMed ID: 10661335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
    Dziggel L; Gebauer N; Bartscht T; Schild SE; Rades D
    Anticancer Res; 2018 Apr; 38(4):2391-2394. PubMed ID: 29599366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04.
    Murray KJ; Scott C; Zachariah B; Michalski JM; Demas W; Vora NL; Whitton A; Movsas B
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):59-64. PubMed ID: 10924972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of five or more brain metastases with stereotactic radiosurgery.
    Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation.
    Bernhardt D; Bozorgmehr F; Adeberg S; Opfermann N; von Eiff D; Rieber J; Kappes J; Foerster R; König L; Thomas M; Debus J; Steins M; Rieken S
    Lung Cancer; 2016 Nov; 101():76-81. PubMed ID: 27794411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer.
    Rades D; Hansen HC; Schild SE; Janssen S
    Lung; 2019 Jun; 197(3):321-326. PubMed ID: 30927058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer - a retrospective analysis.
    Bartsch R; Fromm S; Rudas M; Wenzel C; Harbauer S; Roessler K; Kitz K; Steger GG; Weitmann HD; Poetter R; Zielinski CC; Dieckmann K
    Radiother Oncol; 2006 Sep; 80(3):313-7. PubMed ID: 16959347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors affecting the outcome of brain metastases from breast cancer.
    Liu MT; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Huang CY; Liou CH
    Support Care Cancer; 2006 Sep; 14(9):936-42. PubMed ID: 16575571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.
    Komosinska K; Kepka L; Niwinska A; Pietrzak L; Wierzchowski M; Tyc-Szczepaniak D; Kaczmarczyk A; Bujko K
    Acta Oncol; 2010 Apr; 49(3):382-8. PubMed ID: 20397770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy.
    Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
    Anticancer Res; 2018 May; 38(5):3111-3114. PubMed ID: 29715148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for patients with microsurgically resected brain metastases.
    Korinth MC; Delonge C; Hütter BO; Gilsbach JM
    Onkologie; 2002 Oct; 25(5):420-5. PubMed ID: 12415195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.
    Feyer P; Sautter-Bihl ML; Budach W; Dunst J; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R
    Strahlenther Onkol; 2010 Feb; 186(2):63-69. PubMed ID: 20127222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.